Clinical Trial Update: Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and efficacy study of JV-GL1 in open-angle glaucoma or ocular hypertension has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• JV-GL1

Snippet

Sponsor: JeniVision, Inc. | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 1, Phase 2 | Status: SUSPENDED